Although numerous TAAs have been detected in HNSCC, the current literature on CAR‐T treatments report those targeting CD7027 and human epidermal growth receptor factor 2 (Her2).28 Therefore, it is important to broaden the HNSCC‐specific targets of CAR‐T cells. Here, ERBB2 is linked to head and neck squamous cell carcinoma.